S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
NASDAQ:ZIMV

ZimVie (ZIMV) Stock Price, News & Analysis

$16.31
+0.39 (+2.45%)
(As of 03/27/2024 ET)
Today's Range
$15.92
$16.42
50-Day Range
$15.92
$20.69
52-Week Range
$6.46
$20.91
Volume
339,930 shs
Average Volume
367,939 shs
Market Capitalization
$441.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.00

ZimVie MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.67 Rating Score
Upside/​Downside
1.9% Downside
$16.00 Price Target
Short Interest
Healthy
2.47% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.93mentions of ZimVie in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.17 out of 5 stars

Medical Sector

932nd out of 939 stocks

Dental Equipment & Supplies Industry

3rd out of 3 stocks

ZIMV stock logo

About ZimVie Stock (NASDAQ:ZIMV)

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.

ZIMV Stock Price History

ZIMV Stock News Headlines

Multiple Reasons for the Surge of ZimVie (ZIMV) in Q4
[BUY ALERT] Our #1 A.I. Stock for March
It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.
ZimVie Inc. (ZIMV) Q4 2023 Earnings Call Transcript
Q4 2023 ZimVie Inc Earnings Call
[BUY ALERT] Our #1 A.I. Stock for March
It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.
ZimVie Inc. (NASDAQ:ZIMV) Q4 2023 Earnings Call Transcript
Recap: ZimVie Q4 Earnings
What Wall Street expects from ZimVie's earnings
ZIMV Mar 2024 15.000 put
ZIMV Apr 2024 10.000 call
ZIMV Mar 2024 15.000 call
ZimVie: Shrinking Its Way To Profitability
ZimVie Inc Ordinary Shares
ZimVie Surges On Decision To Sell Its Spine Business To H.I.G. Capital
See More Headlines
Receive ZIMV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ZimVie and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2024
Today
3/27/2024
Next Earnings (Estimated)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Dental equipment & supplies
Sub-Industry
N/A
Current Symbol
NASDAQ:ZIMV
Fax
N/A
Employees
2,600
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$16.00
High Stock Price Target
$16.00
Low Stock Price Target
$16.00
Potential Upside/Downside
-1.9%
Consensus Rating
Reduce
Rating Score (0-4)
1.67
Research Coverage
3 Analysts

Profitability

Net Income
$-393,280,000.00
Pretax Margin
-11.12%

Debt

Sales & Book Value

Annual Sales
$457.43 million
Cash Flow
$4.90 per share
Book Value
$15.43 per share

Miscellaneous

Free Float
26,269,000
Market Cap
$441.67 million
Optionable
Optionable
Beta
2.21
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Mr. Richard J. Heppenstall (Age 53)
    Executive VP, CFO & Treasurer
    Comp: $749.83k
  • Mr. Indraneel Kanaglekar (Age 46)
    Senior VP & President of Global Dental
    Comp: $534.5k
  • Ms. Rebecca A. Whitney (Age 47)
    Senior VP & President of Global Spine
    Comp: $622.97k
  • Sandra Schneider
    Chief Accounting Officer
  • Mr. Steve Rondeau
    Senior VP & Chief Information Officer
  • Ms. Heather Kidwell (Age 55)
    Senior VP, Chief Legal, HR & Compliance Officer and Corporate Secretary
    Comp: $460.18k
  • Ms. Laura Driscoll
    Vice President of Communications
  • Ms. Ann Vu
    Senior Vice President of Regulatory Affairs, Quality Assurance & Clinical

ZIMV Stock Analysis - Frequently Asked Questions

Should I buy or sell ZimVie stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ZimVie in the last twelve months. There are currently 1 sell rating and 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" ZIMV shares.
View ZIMV analyst ratings
or view top-rated stocks.

What is ZimVie's stock price target for 2024?

3 analysts have issued 12 month price targets for ZimVie's stock. Their ZIMV share price targets range from $16.00 to $16.00. On average, they anticipate the company's share price to reach $16.00 in the next year. This suggests that the stock has a possible downside of 1.9%.
View analysts price targets for ZIMV
or view top-rated stocks among Wall Street analysts.

How have ZIMV shares performed in 2024?

ZimVie's stock was trading at $17.75 on January 1st, 2024. Since then, ZIMV stock has decreased by 8.1% and is now trading at $16.31.
View the best growth stocks for 2024 here
.

When is ZimVie's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our ZIMV earnings forecast
.

How were ZimVie's earnings last quarter?

ZimVie Inc. (NASDAQ:ZIMV) issued its quarterly earnings results on Wednesday, February, 28th. The company reported $0.10 earnings per share for the quarter. The company earned $113.07 million during the quarter. ZimVie had a negative net margin of 51.33% and a positive trailing twelve-month return on equity of 2.44%.

What ETF holds ZimVie's stock?

Schwab Ariel ESG ETF holds 1,617 shares of ZIMV stock, representing 0.08% of its portfolio.

What guidance has ZimVie issued on next quarter's earnings?

ZimVie issued an update on its first quarter 2024 earnings guidance on Wednesday, February, 28th. The company provided EPS guidance of for the period. The company issued revenue guidance of $115.0 million-$118.0 million.

Who are ZimVie's major shareholders?

ZimVie's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (6.64%), Vanguard Group Inc. (6.51%), Neuberger Berman Group LLC (5.16%), Kent Lake Capital LLC (3.77%), Charles Schwab Investment Management Inc. (2.87%) and LSV Asset Management (2.84%). Insiders that own company stock include Richard Heppenstall, Sally Crawford and Vafa Jamali.
View institutional ownership trends
.

How do I buy shares of ZimVie?

Shares of ZIMV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ZIMV) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners